2021-02-22T08:47:29-06:00May 13, 2020|Portfolio News|

Brookside Mezzanine Partners is pleased to announce a successful exit from its investment in Water-Jel Technologies Holding Co., LLC (“Water-Jel”), a portfolio company of Brookside Mezzanine Fund III, LP. Water-Jel is a leading manufacturer of branded and private label specialty medical products, specializing in emergency first aid burn care applications and over-the-counter pharmaceutical preparations. It is a highly-recognized market leader in emergency burn care for industrial and retail markets, as well as for the U.S. military, European Emergency Medical Services and Formula-1 Racing.

In May 2016, Brookside Mezzanine Partners provided subordinated debt and an equity co-investment to support the acquisition of Water-Jel by Pilgrim Capital Partners, LLC, a private equity firm that invests in lower middle-market companies.

“Brookside Mezzanine Partners was an important financing partner and we appreciate their support over the last four years” said Chris Daley, Co-Founder of Pilgrim Capital Partners.

“We are delighted to have been selected by Pilgrim Capital Partners and have the opportunity to work with them and the team at Water-Jel,” said David Buttolph, Managing Partner & Founder of Brookside Mezzanine Partners. “We are pleased with the attractive investment outcome for our limited partners. We wish the team of Water-Jel further success as they continue to execute their growth strategy.“

About Brookside Mezzanine Partners

Founded in 2001, Brookside Mezzanine Partners has raised $900 million across four funds. The Firm is a leading provider of debt and minority equity to small and mid-sized companies throughout the United States. We invest in both sponsored and non-sponsored transactions, providing flexible capital solutions to support buyouts, leveraged recapitalizations, strategic acquisitions, dividends and growth capital.

Please contact us or visit our website at brooksidecp.com for additional information. We welcome investment proposals and promise a prompt and confidential response.

Back to News